# VanEck Biotech ETF (BBH) — Overview

BBH · NASDAQ · Fund

Canonical page: https://www.lighthorse.io/tickers/bbh

## Price

Last close $246.49 on Oct 15, 2026. 52-week range $173.52 – $246.49.

## Fund profile

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

| Metric | Value |
| --- | --- |
| Issuer | Van Eck Associates Corporation |
| Industry | Healthcare |
| Inception | Dec 20, 2011 |
| Assets under management | $486.1M |
| Expense ratio | 0.35% |
| Net asset value | $241.05 (as of Oct 14, 2026) |
| Distributions | Annually |
| Leverage | 1x |

## Frequently Asked Questions

### What is VanEck Biotech ETF (BBH)?

BBH tracks a market-cap-weighted index of the 25 largest biotech firms globally.

### What is BBH's expense ratio?

VanEck Biotech ETF charges an annual expense ratio of 0.35%. The fund is issued by Van Eck Associates Corporation.

### How large is BBH?

VanEck Biotech ETF manages $486.1M in assets and has traded since Dec 20, 2011.

### How do I buy shares of VanEck Biotech ETF (BBH)?

BBH trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).